Annovis Share Price

Annovis Share Price

NYSE: ANVS | Micro Cap | Healthcare
$0.82
+$0.07 (9.77%) Last updated on 19 Nov, 2026 | 01:02 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Annovis Stock Performance

Open
$0.76
Prev. Close
$0.74
Circuit Range
N/A
Day Range
$0.74 - $0.82
Year Range
$0.62 - $5.50
Volume
19,929
Average Traded
$0.77

Annovis Share Price Today

As of 19 November 2026, Annovis Bio, Inc.'s share price is $0.82. The stock opened at $0.76, compared to its previous close of $0.74. During today's trading session, Annovis Bio, Inc.'s share price traded between $0.74 and $0.82, with an average price of $0.78. Over the past 52 weeks, the stock has recorded a high of $5.50 and a low of $0.62. In terms of performance, Annovis Bio, Inc.'s share price has declined by 57.50% over the last six months and is down 84.00% on a year-on-year basis.

Annovis Share Price Chart

Line chart of the Annovis price trend over the selected period. The price rose overall, ranging from 0.74 to 0.82, ending at 0.82.
$0.74$0.82
L
Show Current Price
H

Annovis Stock Fundamentals & Key Indicators

Market Cap
$16.77M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.20
Revenue (TTM)
$0.00
Return On Equity (TTM)
390.85%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
3.76%

Annovis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.83-$17.61-$14.82-$9.46
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-79.15%15.84%36.17%

Annovis Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$25.33-$56.20-$24.59-$28.85
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-121.87%56.25%-17.32%

Annovis Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.00.00.0
Current Assets21.0813.9310.2136.02
Total Assets21.0813.9310.2136.02
Non Current Liabilities0.60.7413.680.0
Current Liabilities3.643.884.287.7
Total Liabilities4.234.6217.967.7
Shareholders' Equity16.859.31-7.7528.32

Annovis Cash Flow

Annually
Particulars2025202420232022
Operating (USD Million)-25.62-21.89-39.97-17.31
Investing (USD Billion)0.00.00.00.0
Financing (USD Million)34.626.6917.340.0

About Annovis

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Annovis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.17
$0.82
-27.79%
Oct 2026
$1.26
$1.13
-11.72%
Sep 2026
$1.69
$1.28
-28.89%
Aug 2026
$1.75
$1.80
+2.86%
Jul 2026
$1.89
$1.75
-5.66%
Jun 2026
$1.96
$1.85
-3.39%
May 2026
$1.98
$1.92
-2.54%
Apr 2026
$2.26
$1.97
-11.26%
Mar 2026
$2.56
$2.22
-17.16%
Feb 2026
$2.70
$2.68
+0.00%
Jan 2026
$3.40
$2.68
-21.64%
Dec 2025
$5.09
$3.42
-32.94%

Annovis Share Price FAQs